Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-19

Clinical Trial Update: Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome)

View source ↗

Summary

Astellas Pharma Europe has completed a clinical trial evaluating treatment for storage symptoms in men with lower urinary tract symptoms (overactive bladder).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Lower Urinary Tract Predominant Storage Symptoms | Status: COMPLETED